Phibro Animal Health Corporation
NASDAQ:PAHCDrug Manufacturers - Specialty & Generic
+$0.38 today
- Market cap
- $1.44B
- Beta
- 0.46
- P/E (TTM)
- 13.3
- EPS (TTM)
- $2.35
- Dividend yield
- 1.54%
Volume 0.11M
Average 0.37M
PAHC Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Phibro Animal Health CorporationNASDAQ: PAHC
Other Current Assets · Q3 FY2026 · quarter ended Mar 2026
Other current assets falls 7.3% from a year ago
Other current assets stood at $55.37M at the end of Q3 FY2026, down 7.3% from a year earlier and up 1.7% from the prior quarter. Over 3 fiscal years it compounded at +7.5% a year.
Context
- Other current assets amounted to 3.8% of total assets at the end of Q3 FY2026, down 0.7 pp from a year earlier.
- Other current assets increased in 2 of the last 3 fiscal years.
What to watch
Whether other current assets keeps falling in the next quarterly balance sheet after a -7.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 61.16M USD
- Year-over-year change
- +19.9%
- 4-year CAGR
- +9.5%
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 61.16M | +19.9% |
| FY2024 | 2024-06-30 | 51.02M | -19.5% |
| FY2023 | 2023-06-30 | 63.39M | +28.6% |
| FY2022 | 2022-06-30 | 49.29M | +15.9% |
| FY2021 | 2021-06-30 | 42.53M | — |
Other Current Assets vs competitors
How PAHC compares with its peers on the latest reported figures
- Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -7.3% is the lowest of 6, against a peer median of +24.6%.
- Other current assets amounts to 3.8% of total assets for PAHC, versus a peer median of 3.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $10.77B USD | +7.7% | +9.8% | 8.3% | |
| Jun 2026 | $535M USD | +5.1% | +5.7% | 3.5% | |
| Sep 2026 | $380M USD | +24.6% | -15.7% | 2.8% | |
| Aug 2026 | $128.2M USD | +140.5% | +33.9% | 3.9% | |
| Mar 2026 | $55.37M USD | -7.3% | +7.5% | 3.8% | |
| Dec 2025 | CN¥6.78M CNY | +338700.0% | -18.4% | 1.6% | |
| Peer median (excluding PAHC) | — | +24.6% | +5.7% | 3.5% | |
Competitors are the stored peer set for PAHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 50.21M | 74.25M | 41.28M | 70.61M | 68.04M |
| Short-term Investments | 43M | 17M | 40M | 44M | 9M |
| Net Receivables | 146.85M | 166.54M | 163.48M | 169.45M | 227.98M |
| Inventory | 216.31M | 259.16M | 277.57M | 265.91M | 444.43M |
| Other Current Assets | 42.53M | 49.29M | 63.39M | 51.02M | 61.16M |
| Total Current Assets | 498.91M | 566.23M | 585.72M | 601M | 810.61M |
| Property, Plant & Equipment (Net) | 187.67M | 203.17M | 231.33M | 240.9M | 396.03M |
| Goodwill | 52.68M | 53.23M | 53.27M | 54.56M | 59.65M |
| Intangible Assets | 62.28M | 63.86M | 54.99M | 45.03M | 36.47M |
| Long-term Investments | 10.11M | 10.35M | 11.09M | 11.49M | 11.69M |
| Tax Assets | 9.86M | 5.85M | 8.71M | 19.37M | 25.55M |
| Other Non-current Assets | 19.82M | 29.02M | 26.28M | 9.83M | 20.91M |
| Total Non-current Assets | 342.42M | 365.47M | 385.67M | 381.19M | 550.29M |
| Total Assets | 841.33M | 931.7M | 971.4M | 982.18M | 1.36B |
| Account Payables | 68.36M | 95.6M | 73.85M | 85.57M | 138.2M |
| Short-term Debt | 9.38M | 15M | 22.3M | 29.8M | 16.25M |
| Tax Payables | 6.11M | 7.21M | 8.66M | 2.93M | 8.4M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 56.21M | 53.18M | 48.22M | 55.15M | 83M |
| Total Current Liabilities | 164.12M | 190.83M | 176M | 204.15M | 293.47M |
| Long-term Debt | 382.71M | 417.93M | 452.54M | 458.29M | 702.44M |
| Deferred Tax Liabilities | 6.65M | 9.26M | 12.15M | 14.22M | 19.47M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 21.32M | 19.73M | 19.12M | 18.97M | 26.1M |
| Total Non-current Liabilities | 438.68M | 478.43M | 512.89M | 521.4M | 781.75M |
| Total Liabilities | 602.8M | 669.26M | 688.89M | 725.54M | 1.08B |
| Common Stock | 4K | 4K | 4K | 4K | 4K |
| Retained Earnings | 218.02M | 247.75M | 260.91M | 243.89M | 272.7M |
| Accumulated OCI | (115.29M) | (121.11M) | (114.21M) | (123.53M) | (124.02M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 238.53M | 262.44M | 282.51M | 256.64M | 285.68M |
| Total Debt | 426.71M | 470.48M | 509.97M | 525.46M | 761.55M |
| Net Debt | 376.49M | 396.24M | 468.69M | 454.85M | 693.51M |
Phibro Animal Health Corporation
NASDAQ:PAHC
Intrinsic Alpha fair value
Locked
Current Price
$35.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.